« Back to Record
Loi, S., Savas, P., Lönnstedt, I. I., Fumagalli, D., Caramia, F., Li, J., Salgado, R., Rowan, A., Andre, F., Denkert, C., Neven, P., Loibl, S., Sotiriou, C., Swanton, C., & Speed, T. P. (2014). Evaluation and clinical impact of intra-tumor heterogeneity (ITH) in primary HER2-overexpressing breast cancers (HER2+BC) treated with adjuvant trastuzumab and chemotherapy (CT). Poster session presented at San Antonio Breast Cancer Symposium – SABCS (December 11, 2014: San Antonio, Tx, USA).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/244775



